• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Survival of patients with classical Hodgkin lymphoma in Finland: a national population-based analysis.

作者信息

Hannuksela Noora, Partanen Anu, Anttalainen Anna, Ukkola-Vuoti Liisa, Toppila Iiro, Vikkula Johanna, Marin Katja, Kuitunen Hanne, Miettinen Tatu, Kuittinen Outi, Rönkä Aino

机构信息

Oncology, Faculty of Health Medicine, School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Department of Medicine, Kuopio University Hospital, Wellbeing Services County of Northern Savo, Kuopio, Finland.

出版信息

Blood Cancer J. 2024 Aug 20;14(1):139. doi: 10.1038/s41408-024-01125-4.

DOI:10.1038/s41408-024-01125-4
PMID:39164236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11335738/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4548/11335738/4b2847344653/41408_2024_1125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4548/11335738/4b2847344653/41408_2024_1125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4548/11335738/4b2847344653/41408_2024_1125_Fig1_HTML.jpg

相似文献

1
Survival of patients with classical Hodgkin lymphoma in Finland: a national population-based analysis.芬兰经典型霍奇金淋巴瘤患者的生存率：一项基于全国人口的分析。
Blood Cancer J. 2024 Aug 20;14(1):139. doi: 10.1038/s41408-024-01125-4.
2
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.突尼斯北部经典型霍奇金淋巴瘤青少年及青年患者：一项成人单机构研究的见解
Cancer Radiother. 2020 Jun;24(3):206-214. doi: 10.1016/j.canrad.2020.01.004. Epub 2020 Mar 11.
3
CD20 expression by Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma is related to reduced overall survival in young adult patients.经典型霍奇金淋巴瘤中霍奇金-里德-斯腾伯格细胞的CD20表达与年轻成年患者的总生存期缩短有关。
Leuk Lymphoma. 2008 Nov;49(11):2198-202. doi: 10.1080/10428190802239170.
4
Epidemiology of classic and nodular lymphocyte predominant hodgkin lymphoma in Finland in 1996-2015.芬兰 1996-2015 年经典型和结节性淋巴细胞为主型霍奇金淋巴瘤的流行病学。
Acta Oncol. 2020 May;59(5):574-581. doi: 10.1080/0284186X.2019.1711166. Epub 2020 Jan 7.
5
Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.原发性纵隔弥漫大 B 细胞淋巴瘤/经典型霍奇金淋巴瘤后复合及序贯性淋巴瘤患者的生存：一项基于人群的研究。
Leuk Res. 2021 Dec;111:106669. doi: 10.1016/j.leukres.2021.106669. Epub 2021 Jul 16.
6
Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.霍奇金淋巴瘤组织学亚型中继发性非霍奇金淋巴瘤的不同生存率和风险：一项基于人群的研究。
Leuk Lymphoma. 2014 Jul;55(7):1570-7. doi: 10.3109/10428194.2013.847938. Epub 2013 Nov 12.
7
Primary therapy and relative survival in classical Hodgkin lymphoma: a nationwide population-based study in the Netherlands, 1989-2017.原发性治疗与经典型霍奇金淋巴瘤的相对生存率：荷兰 1989-2017 年全国性基于人群的研究。
Leukemia. 2021 Feb;35(2):494-505. doi: 10.1038/s41375-020-0875-0. Epub 2020 May 28.
8
Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data.2000年至2014年美国结节性淋巴细胞为主型霍奇金淋巴瘤：基于监测、流行病学和最终结果（SEER）数据的最新分析
Br J Haematol. 2018 Sep;182(5):727-730. doi: 10.1111/bjh.14861. Epub 2017 Jul 24.
9
Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.经典型霍奇金淋巴瘤，淋巴细胞消减型：临床病理分析及与其他经典型霍奇金淋巴瘤类型的预后比较。
Pathol Res Pract. 2013 Apr;209(4):201-7. doi: 10.1016/j.prp.2012.11.003. Epub 2013 Mar 9.
10
Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.美国晚期经典型霍奇金淋巴瘤的当代结果：监测、流行病学和最终结果数据库分析。
Oncologist. 2019 Nov;24(11):1488-1495. doi: 10.1634/theoncologist.2019-0172. Epub 2019 Aug 29.

本文引用的文献

1
Long-term cause-specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens-A nationwide Danish cohort study.采用当代方案治疗的青少年和青年霍奇金淋巴瘤患者的长期特定病因死亡率——一项丹麦全国队列研究
Br J Haematol. 2024 Oct;205(4):1374-1382. doi: 10.1111/bjh.19586. Epub 2024 Jun 12.
2
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.自体造血干细胞移植后进展的 cHL 患者的总生存：新型药物时代的结果。
Blood Adv. 2023 Dec 12;7(23):7295-7303. doi: 10.1182/bloodadvances.2023011205.
3
Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment.
北欧国家半个世纪以来血液恶性肿瘤的生存情况与治疗的相关性。
Leukemia. 2023 Apr;37(4):854-863. doi: 10.1038/s41375-023-01852-w. Epub 2023 Feb 24.
4
Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.21 世纪初常见血液系统恶性肿瘤诊断后长期生存的变化。
Blood Cancer J. 2020 May 13;10(5):56. doi: 10.1038/s41408-020-0323-4.
5
Risk of multiple primary malignancies following treatment of Hodgkin lymphoma.霍奇金淋巴瘤治疗后的多原发性恶性肿瘤风险。
Blood. 2014 Jul 17;124(3):319-27; quiz 466. doi: 10.1182/blood-2013-10-532184. Epub 2014 Apr 16.
6
Incidence patterns and outcomes for hodgkin lymphoma patients in the United States.美国霍奇金淋巴瘤患者的发病模式及治疗结果
Adv Hematol. 2011;2011:725219. doi: 10.1155/2011/725219. Epub 2010 Dec 16.
7
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.早期霍奇金淋巴瘤患者的治疗强度降低。
N Engl J Med. 2010 Aug 12;363(7):640-52. doi: 10.1056/NEJMoa1000067.
8
Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.1981 - 2005年美国青少年或青年期血液系统恶性肿瘤诊断后的生存趋势
Cancer. 2009 Nov 1;115(21):4973-9. doi: 10.1002/cncr.24548.
9
Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.联合治疗与单纯放疗治疗早期霍奇金病：治愈与并发症的权衡
J Clin Oncol. 2006 Feb 1;24(4):605-11. doi: 10.1200/JCO.2005.02.9850.
10
Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma.
J Clin Oncol. 2006 Feb 1;24(4):544-8. doi: 10.1200/JCO.2005.04.4396.